Neurogene Inc. SEC filings NGNE
Neurogene Inc. has 750 filings in SEC EDGAR's recent list, going back to Jun 25, 2007. Its latest annual report, Form ARS, was filed on Apr 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 11, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Apr 16, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Mar 24, 2026 | Dec 31, 2025 |
| ARS | Annual report to shareholders | Apr 25, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Mar 24, 2025 | Dec 31, 2024 |
| ARS | Annual report to shareholders | Apr 26, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Mar 18, 2024 | Dec 31, 2023 |
| ARS | Annual report to shareholders | Apr 27, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Mar 20, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Mar 1, 2022 | Dec 31, 2021 |
| 10-K | Annual report | Mar 25, 2021 | Dec 31, 2020 |
| 10-K | Annual report | Mar 12, 2020 | Dec 31, 2019 |
| 10-K/A | Amended annual report | Apr 15, 2019 | Dec 31, 2018 |
| 10-K | Annual report | Mar 7, 2019 | Dec 31, 2018 |
| 10-K | Annual report | Mar 12, 2018 | Dec 31, 2017 |
| 10-K | Annual report | Mar 9, 2017 | Dec 31, 2016 |
| 10-K | Annual report | Mar 14, 2016 | Dec 31, 2015 |
| ARS | Annual report to shareholders | Mar 30, 2015 | Dec 31, 2014 |
| 10-K | Annual report | Mar 16, 2015 | Dec 31, 2014 |
Showing 18 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- NGNE (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1404644
- Former names
- Neoleukin Therapeutics, Inc. (until Dec 6, 2023); AQUINOX PHARMACEUTICALS, INC (until Aug 12, 2019); AQUINOX PHARMACEUTICALS (USA) INC (until Dec 24, 2013)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.